After a seemingly endless period of review, the FDA has approved the genetically modified (GM) AquaBounty salmon for sale and consumption. Update: You might find my interview with George Church on CRISPR and gene modification interesting. I don’t see any particular reason to think that this GM fish as a food would pose any significant …
FDA approves 1st GM animal (fast-growing salmon) to eat Read More »
CRISPR-ful Noah’s Ark? Even as much of the discussion surrounding powerful new gene editing and cloning technologies has centered on their possible use in humans, the creation of genetically modified (GM) and cloned animals has advanced at warp speed. Some of these efforts have been for research, which is justified. But many seem profit-centered and …
Noah’s GMO ark: is it ethical to create GM or cloned animals for sale as pets? Read More »
I just did a blog post today on the striking story of someone doing DIY CRISPR gene therapy on themselves. A question came to mind. How long until someone does a DIY attempt to CRISPR themselves? In the DIY gene therapy story, the person was injected with so-called “gain-of-function” viruses to try to reap health …
Tick Tock Genetic Clock: How soon until first DIY CRISPR of self? Read More »
Who will be speaking at the upcoming National Academy of Sciences (NAS) meeting on human gene editing? So far we haven’t known, but now we do (if you are eager to find out, skip to bottom of the post). The organizers of the meeting can be found here. Keep in mind that it is probable that …
List of Speakers for NAS Meeting on Human Gene Editing Read More »
Below is a conversation with bioethics commentator Kelly Hills (who BTW has a great blog), tackling some of the key issues surrounding the potential use of CRISPR-Cas9 technology to make heritable human genetic modification. I really appreciate her clear and insightful answers to some tough questions that many are grappling with today on this topic. Part …
Kelly Hills interview: human genetic modification & bioethics Read More »
In a poll on CRISPR, respondents so far have predominantly viewed potential off-target effects as a moderate (28%) to substantial (25%) problem. The poll is still running if you are interested in participating. As to the more polar answers, only 20% and 4% answered “minor” or “a non-issue”, respectively, while 14% thought that off-target effects …
CRISPR off-target effects important, but not severe challenge, says poll Read More »
The US Congress recently held its first hearing on human germline genetic modification. The meeting included CRISPR-Cas9 pioneer Jennifer Doudna (see video here) on the panel. See image of Cas9 structure from Wikipedia. CRISPR-Cas9 is a powerful, strikingly efficient tool for genetic engineering of cells and whole organisms. Now Republican congressional leaders have included a …
Congress: FDA should consult religious experts on embryo CRISPR Read More »
The House Subcommittee on Research and Technology on Tuesday held a CRISPR hearing: “The Science and Ethics of Genetically Engineered Human DNA”. At the meeting, CRISPR pioneer Dr. Jennifer Doudna gave testimony along with Dr. Victor Dzau who is the President of the Institute of Medicine (IOM) of the National Academy of Sciences (NAS), Dr. …
Doudna & Others Testify to Congress on CRISPR, Human Germline Editing Read More »
As CRISPR gene editing technology has advanced in the last few years, the number of genetically modified animals made with this system has steadily increased. Some are very interesting and useful for science. At the same time especially when they are little, they can be very cute. A nickname is going around for these GM …
CRISPR critters: Cute pics of Cas9 gene edited animals Read More »
A decade ago I wrote an article in the journal Nature Biotechnology about the rise of a new gene editing technology called zinc finger nucleases (ZNF). It was one of those “drumbeat” discoveries: at the time, my sense was it would revolutionize how we deliver genes to cells and tissues, and profoundly change the way …
Guest Post by Chris Scott–The Great CRISPR Controversy: What’s Next? Read More »